DC Field | Value | Language |
---|---|---|
dc.contributor.author | J H Kang | - |
dc.contributor.author | Y Kim | - |
dc.contributor.author | S H Won | - |
dc.contributor.author | Song Kyu Park | - |
dc.contributor.author | Cahng Woo Lee | - |
dc.contributor.author | Hwan Mook Kim | - |
dc.contributor.author | N E Lewin | - |
dc.contributor.author | N A Perry | - |
dc.contributor.author | L V Pearce | - |
dc.contributor.author | D J Lundberg | - |
dc.contributor.author | R J Surawski | - |
dc.contributor.author | P M Blumberg | - |
dc.contributor.author | J Lee | - |
dc.date.accessioned | 2017-04-19T09:17:17Z | - |
dc.date.available | 2017-04-19T09:17:17Z | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | 10.1016/j.bmcl.2009.12.058 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/9373 | - |
dc.description.abstract | A series of DAG-lactones with polar 3-alkylidene substituents have been investigated as PKC-α ligands and antitumor agents. Extensive analysis of structure-activity relationships for the 3-alkylidene chain revealed that polar groups such as ether, hydroxyl, aldehyde, ester, acyloxy, and amido were tolerated with similar binding affinities and reduced lipophilicities compared to the corresponding unsubstituted alkylidene chain. Among the derivatives, compounds 5, 6 and 8 with an ether type of side chain showed high binding affinities in range of Ki = 3-5 nM and excellent antitumor profiles, particularly against the colo205 colon cancer and the K562 leukemia cell lines. | - |
dc.publisher | Elsevier | - |
dc.title | Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-γ-lactones as protein kinase C ligands and antitumor agents | - |
dc.title.alternative | Polar 3-alkylidene-5-pivaloyloxymethyl-5'-hydroxymethyl-γ-lactones as protein kinase C ligands and antitumor agents | - |
dc.type | Article | - |
dc.citation.title | Bioorganic & Medicinal Chemistry Letters | - |
dc.citation.number | 3 | - |
dc.citation.endPage | 1012 | - |
dc.citation.startPage | 1008 | - |
dc.citation.volume | 20 | - |
dc.contributor.affiliatedAuthor | Song Kyu Park | - |
dc.contributor.affiliatedAuthor | Cahng Woo Lee | - |
dc.contributor.affiliatedAuthor | Hwan Mook Kim | - |
dc.contributor.alternativeName | 강지혜 | - |
dc.contributor.alternativeName | 김예림 | - |
dc.contributor.alternativeName | 원신혜 | - |
dc.contributor.alternativeName | 박성규 | - |
dc.contributor.alternativeName | 이창우 | - |
dc.contributor.alternativeName | 김환묵 | - |
dc.contributor.alternativeName | Lewin | - |
dc.contributor.alternativeName | Perry | - |
dc.contributor.alternativeName | Pearce | - |
dc.contributor.alternativeName | Lundberg | - |
dc.contributor.alternativeName | Surawski | - |
dc.contributor.alternativeName | Blumberg | - |
dc.contributor.alternativeName | 이지우 | - |
dc.identifier.bibliographicCitation | Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 3, pp. 1008-1012 | - |
dc.identifier.doi | 10.1016/j.bmcl.2009.12.058 | - |
dc.subject.keyword | Antitumor activity | - |
dc.subject.keyword | DAG-lactone | - |
dc.subject.keyword | Diacylglycerol | - |
dc.subject.keyword | Protein kinase C | - |
dc.subject.local | anti-tumor activity | - |
dc.subject.local | antitumor activity | - |
dc.subject.local | Antitumor activity | - |
dc.subject.local | DAG-lactone | - |
dc.subject.local | Diacylglycerol | - |
dc.subject.local | Protein kinase C | - |
dc.subject.local | protein kinase C | - |
dc.subject.local | protein kinase c | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.